Mycophenolic acid metabolite profile in renal transplant patients receiving enteric-coated mycophenolate sodium or mycophenolate mofetil

Transplantation Proceedings

Volumn 37, Issue 2, 2005, Pages 852-855

  Tedesco Silva, H ^a   Bastien, M C ^a   Choi, L ^a   Felipe, C ^a   Campestrini, J ^a   Picard, F ^a   Schmouder, R ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

AREA UNDER THE CURVE; CONFERENCE PAPER; CROSSOVER PROCEDURE; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG TOLERABILITY; HUMAN; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL;

EID: 17844380029     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.12.186     Document Type: Conference Paper

References (11)

1. European Mycophenolate Cooperative Study Group Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection Lancet 345 1995 1321
2. Tricontinental Mycophenolate Renal Transplantation Study Group A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation Transplantation 61 1996 1029
3. M. Behrend Adverse gastrointestinal effects of mycophenolate mofetil Drug Safety 24 2001 645
4. K. Budde, J. Curtis, G. Knoll Enteric-coated mycophenolate sodium can be safely administered in maintenance renal transplant patients: results of a 1-year study Am J Transplant 4 2004 237
5. M. Salvadori, H. Holzer, A. de Mattos Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patients Am J Transplant 4 2004 231
6. R.E.S. Bullingham, A.J. Nicholls, B.R. Kamm Clinical pharmacokinetics of mycophenolate mofetil Clin Pharmacokinetics 34 1998 429
7. E. Schuetz, M. Shipkova, V.W. Armstrong Identification of a pharmacologically active metabolite of mycophenolic acid in plasma of transplant recipients treated with mycophenolate mofetil Clin Chem 45 1999 419
8. M. Shipkova, V.W. Armstrong, L. Weber Pharmacokinetics and protein adduct formation of the pharmacologically active acyl glucuronide metabolite of mycophenolic acid in pediatric renal transplant recipients Ther Drug Monit 24 2002 390
9. G.A. Knoll, I. Macdonald, A. Khan Mycophenolate mofetil dose reduction and the risk of acute rejection after renal transplantation J Am Soc Nephrol 14 2003 2381
10. I. Neumann, M. Haidinger, H. Jager Pharmacokinetics of mycophenolate mofetil in patients with autoimmune diseases compared renal transplant recipients J Am Soc Nephrol 14 2003 721
11. N.R. Pumford, N.C. Halmes, J.A. Hinson Covalent binding of xenobiotics to specific proteins in the liver Drug Metab Rev 29 1997 39